Meral Beksac
@mbeksac56Professor of Hematology, Ankara Liv Hospital, Istinye University, plasma cell trials & EMN senior board member, EBMT PCD vice chair, BMSG vice president
Similar User
@TomBmt133
@szusmani
@Mohty_EBMT
@Myeloma_Society
@DrGarethMorgan1
@mvmateos
@Transplant_Doc
@paurotero
@JHillengass
@AnnaSureda5
@DrKrinaPatel
@MayoMyeloma
@thanosdimop
@jmikhaelmd
@COMyCongress
June 2022 ASCO education session: When monoclonal gammopathy is not myeloma. Open access review on SMM, AL Amyloidosis and Waldenström
A medical school student to present such a difficult case: Ebrar Uzun deserves appreciation🏆
Join us for the upcoming Junior Club Transient Response with Elranatamab in a Case of Relapsed Refractory Multiple Myeloma with CNS Involvement 🗓️Tuesday, Nov 19 2024 ⏲️6PM CET 12PM NY Register for FREE ⬇️⬇️ bit.ly/3O3VTBF @mbeksac56 @Florent_Malard @Mohty_EBMT
Türkiye’nin milli ve yerli bir ilaç politikası yoktur! Türkiye ilaçta tamamen dışa bağımlıdır! Türk insanının ilaca ulaşımı kısıtlanmıştır. Yine vatandaşlarımızın Avrupa ve Amerikaya kıyasla sadece %15’i yenilikçi ilaçlara ulaşabilmektedir. Türkiye 7 milyar dolarlık bir ilaç…
Similar to familial MM which has better prognosis than non-familial MM, AFA though more susceptible than CAU to MM looks like w better prognostic features
- 766 Whole Genome Sequencing Reveals Lower Apobec-Mutational Activity in Multiple Myeloma Patients with African Ancestry Compared with Those Having European Ancestry ash.confex.com/ash/2024/webpr… - 592 Convergent Evolution Towards CD38 Biallelic Loss Is a Recurrent Mechanism of…
A novel and promising approach thanks for sharing
**Clinical Abstracts - RRMM: 1029 CAR-T Cell Therapy in Advanced Myeloma with Extramedullary Disease – an In Vivo Imaging and Molecular Monitoring Study (CARAMEL): First Results of Cu-64 Radiolabelled Nanoparticle PET-CT and PET-MRI ash.confex.com/ash/2024/webpr… 1031 Phase 2…
Our new @NatureAging paper: We built 14 "biological clocks" representing the biological age and rate of aging of 14 major body systems using data from 13,000 people of the Human Phenotype Project Key findings: 1. Biological clocks are clinically meaningful: People with higher…
Happening this evening at 8 pm Turkey, 6 pm Paris, 7 pm Athens time
Join us @TheIACH Impact of prior treatment on selinexor,bortezomib, dexamethasone outcomes in patients with relapsed/refractory MM: Extended F/U subgroup analysis of the BOSTON trial 🗓️Nov 5 ⏲️6PM CET Register for 🆓 bit.ly/4fqN8gz @Mohty_EBMT @mbeksac56 @thanosdimop
Uzun bir eğitim yolculuğunun ilk kismini bitiriyoruz ama bu daha başlangıç bu yolculugun her anı icin mentorlugunuz için cok teşekkür ederiz; @mbeksac56 @guldaneseval ve ayse salihoğlu. eksiklerimiz olsa da bir arada olmak çok güzeldi. Multiple myeloma masterclass 2024
Elena Zamagni of @unibo talks on the role of imaging in the management of extramedullary disease #iwHRMM24 #HemOnc #MultipleMyeloma #Myeloma
An economist born in Istanbul, UK University graduate , currently a USA academician with both Turkish and USA citizenship but his studies in economics have global, timeless impactful value.
“You dream of having a good career but this is over and on top of that. It’s a great surprise and honour.” Daron Acemoglu (@DAcemogluMIT) reacting to the news of his prize in economic sciences today. Congratulations to our new laureate! #NobelPrize
Bilim Akademisi üyesi Daron Acemoglu 2024 Nobel İktisat Ödülünü aldı! “Kurumların oluşumu ve refaha etkilerine” ilişkin çalışmalarından dolayı verilen Nobel ödülü, ekonomi alanında dünyanın en prestijli bilim ödüllerinden biri olarak kabul ediliyor. bilimakademisi.org/bilim-akademis…
Top class article by the top class speaker and giants in the field @Mohty_EBMT @TheIACH chi.scholasticahq.com/article/124436
"From MGUS to multiple myeloma: Unraveling the unknown of precursor states": up-to-date review article - current status & future directions - now available online in Blood Reviews: authors.elsevier.com/a/1jvWg,67OtzD… #mmsm @IMFmyeloma @theMMRF @HealthTree @ASH_hematology @SylvesterCancer
Great session by @awechalekar on AL amyloidosis! Early recognition is crucial for this elusive, high-morbidity disease. Screening, new imaging techniques and updated staging systems needed; GLS on echo shows prognostic value. #ESHMM2024 #ESHConferences #MMsm
Insights from @SLentzsch on clearing amyloid fibrils to improve organ responses. Anselamimab improves GLS; awaiting Phase 3. Birtamimab disaggregates toxic LC aggregates, aiding macrophages, improving OS/QOL. Stay tuned for CAR macrophages! #ESHMM2024 #ESHCONFERENCES #MMsm
#ESHMM2024 Thank you Hartmut Goldschmidt @MyMKaiser & @SLentzsch & all our faculty for these great 3 days! Thanks also to all participants for engaging so actively with comments & questions! See you next year in Vienna for the 5th How to Diagnose and Treat #MMsm! #ESHCONFERENCES
United States Trends
- 1. $CUTO 6.621 posts
- 2. $CATEX N/A
- 3. $XDC 1.239 posts
- 4. DeFi 102 B posts
- 5. #Caturday 7.305 posts
- 6. GAME DAY N/A
- 7. Good Saturday 34,9 B posts
- 8. #saturdaymorning 2.948 posts
- 9. #SaturdayVibes 4.397 posts
- 10. #Arcane 273 B posts
- 11. Jayce 75,3 B posts
- 12. Senior Day 2.756 posts
- 13. #MSIxSTALKER2 5.477 posts
- 14. Pence 83,3 B posts
- 15. Renji 2.951 posts
- 16. McCormick-Casey 26,8 B posts
- 17. $XRP 94,8 B posts
- 18. Pennsylvania Democrats 117 B posts
- 19. Tyquan Thornton N/A
- 20. Fetterman 41,8 B posts
Who to follow
-
Tom Martin
@TomBmt133 -
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰
@szusmani -
Mohamad Mohty
@Mohty_EBMT -
Myeloma Society
@Myeloma_Society -
Gareth Morgan
@DrGarethMorgan1 -
marivi mateos
@mvmateos -
Muzaffar Qazilbash
@Transplant_Doc -
Paula Rodriguez-Otero
@paurotero -
Jens Hillengass
@JHillengass -
Anna Sureda
@AnnaSureda5 -
Krina Patel
@DrKrinaPatel -
Mayo Myeloma
@MayoMyeloma -
Thanos Dimopoulos
@thanosdimop -
Joseph Mikhael
@jmikhaelmd -
COMy
@COMyCongress
Something went wrong.
Something went wrong.